In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Basic Science Summer School 2017

Add to calendar18/06/20170:00 22/06/20170:00 Europe/Paris Basic Science Summer School 2017 Council on Basic Cardiovascular Science contact@escardio.org true DD/MM/YYYY
Basic Sciences, Pharmacology, Genomics and Cardiovascular Pathology
In-person
event


Summer School Group Picture.jpeg

 

Scientific programme by day & resources

Resources are available  by clicking on the title of the presentations.

Sunday 18 June - Novotel Nice Arenas

18:00          Welcome – Course Directors (Chair : Peter Ferdinandy)
18:15           Opening keynote plenary lecture Jörg Menche (Vienna - Austria)
                   Network modelling and analysis in cardiovascular disease

Monday 19 June - European Heart House

Session 1:  Cardioprotection (Chair : Jeremy Fauconnier)
09:00        Key pathways to ischemia-reperfusion injury 
                 
   Sean Davidson (London - United Kingdom)
09:45        Opportunities and challenges in translating cardioprotection to the clinic
                    Gemma Vilahur (Barcelona - Spain)

Session 2:  Cardiac and vascular development (Chair : Giuseppina Caliguri)
11:00           Cardiac development: insights into congenital heart disease
                     Adriana Gittenburger-de Groot (Leiden, Netherlands)
11.45           Origins of vascular smooth muscle cells and implications for disease
                     Sanjay Sinha (Cambridge, United Kingdom)

Session 3:  Thrombosis and coagulation (Chair : Jeremy Pearson)
13:30          Control of thrombosis and fibrinolysis in vivo: implications for new therapies
                     Nicola Mutch (Aberdeen, United Kingdom)
14:15           Novel oral anticoagulants: mechanisms of action and therapeutic indications
                     Raffaele de Caterina (Chieti, Italy)

Session 4:  Publishing your research (Chair : Peter Ferdinandy)
15.15           Getting the experimental design and statistical analysis right ht 
                     Dirk Duncker (Rotterdam, Netherlands)
16.00          Writing the paper: what the journal editors expect
                     Karin Sipido (Leuven, Belgium; Editor in Chief, Cardiovascular Research)

Tuesday 20 June

Session 5:  Novel methods to measure and control cardiomyocyte function (Chair: Jolanda van der Velden)
09.00         Measuring the physiological responses of single cardiomyocytes
                     Michiel Helmes (Ionoptix)
09.45         Optogenetic control of cardiac rhythm
                     Claudia Richter (Göttingen, Germany)            

Session 6:  The immune response and atherogenesis (Chair : Jeremy Pearson)
11.00           The roles of T and B cells
                     Giuseppina Caligiuri (Paris, France)
11.45           Targeting immune receptors to reduce atherosclerosis
                     Norbert Gerdes (Düsseldorf, Germany)

Session 7:  Regenerative medicine (Chair : Gemma Vilahur) 
13.30          Therapeutic angiogenesis: the long road to translation
                     Seppo Ylä-Herttuala (Kuopio, Finland)                  
14.15           Bioengineered grafts for the infarcted heart
                     Antoni Bayés Genis (Barcelona, Spain)

Session 8:  How and why pharma and academia collaborate to develop new medicines (Chair: Jeremy Fauconnier)
15.15           Role of academic research and spin-off (start-up) companies in drug development
                     Peter Ferdinandy (Budapest, Hungary)
15.50         How Big Pharma and academia collaborate
                    
Patricia Sansilvestri-Morel (Suresnes, France)
16.20         Development of advanced therapy medicinal products: need for collaborations with academia and                         specialized R&D companies
                     Swetlana Adamsky (Tel-Aviv, Israel)

Wednesday 21 June

Session 9:  Cardiac contractile dysfunction (Chair : Jolanda van der Velden)
09.00         Cardiometabolic dysregulation, mitochondrial function and arrhythmia
                     Jérémy Fauconnier (Montpellier, France)
09.45         Cardiomyopathies: biology and future treatment options
                     Jolanda van der Velden (Amsterdam, Netherlands)

Session 10:  Non-coding RNAs (Chair : Giuseppina Caliguri)
11:00            Control of cardiac remodelling and fibrosis by ncRNAs
                      Paula da Costa Martins (Maastricht, Netherlands) 
11:45            Control of angiogenesis and arteriogenesis by miRNAs
                      Yaël Nossent (Leiden, Netherlands)

Session 11:  Vulnerable Plaque ( Chair: jeremy Perason)
13:30           The vulnerable plaque – an evolving target?
                      Gerard Pasterkamp (Utrecht, Netherlands)
14:15            Imaging the vulnerable plaque to stratify individual patient risk
                      Marc Dweck (Edinburgh, United Kingdom)

Session 12:  Finding new drug targets: the worlds of informatics and omics (Chair : Peter Ferdinandy)
15.15            The advantages and limitations of proteomics and metabolomics
                      Manuel Mayr (London, United Kingdom)
15.45           Using Mendelian randomization to impute causality in genomic studies
                     Jemma Hopewell (Oxford, United Kingdom)

Thursday 22 June

Session 13:  Building your career 
09.00          Advice from Professor Jeremy Pearson 

Session 14:  iPS cells and personalised medicine (Chair : Gemma Vilahur)
10.30            iPS cell-derived cardiomyocytes for drug testing
                       Daniel Sinnecker (Munich, Germany)
11.15              iPS cell-derived cardiomyocytes: directing phenotype for therapeutic use
                       Chris George (Swansea, United Kingdom)         
12.00           Closing keynote plenary lecture (Chair : Jeremy Pearson)
                     Healthy cardiovascular aging: the life course perspective
                      Mark Hanson (Southampton, United Kingdom)  

Discover more about the ESC Council on Basic Cardiovascular Science